13F HOLDINGS REPORT
COMMODORE CAPITAL LP
Quarter ended Q2 2024 · Filed August 14, 2024 · Accession 0001880562-24-000002
Total Value
$1.47B
Positions
35
Other Managers
0
Confidential Omitted
No
Holdings (35)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | MERUS N V | N5749R100 | 3,200,000 | $189.3M | 12.92% |
| 2 | NUVALENT INC | NUVL | 1,487,756 | $112.9M | 7.70% |
| 3 | XENON PHARMACEUTICALS INC | XENE | 2,754,266 | $107.4M | 7.33% |
| 4 | VAXCYTE INC | PCVX | 1,305,000 | $98.5M | 6.73% |
| 5 | ENLIVEN THERAPEUTICS INC | ELVN | 3,973,245 | $92.9M | 6.34% |
| 6 | VERA THERAPEUTICS INC | VERA | 2,475,000 | $89.5M | 6.11% |
| 7 | COGENT BIOSCIENCES INC | COGT | 9,738,000 | $82.1M | 5.60% |
| 8 | SOLENO THERAPEUTICS INC | SLNO | 1,425,000 | $58.1M | 3.97% |
| 9 | CELLDEX THERAPEUTICS INC NEW | CLDX | 1,425,000 | $52.7M | 3.60% |
| 10 | MIND MEDICINE MINDMED INC | 60255C885 | 7,145,888 | $51.5M | 3.52% |
| 11 | RHYTHM PHARMACEUTICALS INC | RYTM | 1,225,000 | $50.3M | 3.43% |
| 12 | ARVINAS INC | ARVN | 1,884,361 | $50.2M | 3.42% |
| 13 | SPYRE THERAPEUTICS INC | SYRE | 1,988,084 | $46.7M | 3.19% |
| 14 | PERSPECTIVE THERAPEUTICS INC | CATX | 4,657,345 | $46.4M | 3.17% |
| 15 | PHARVARIS N V | PHVS | 1,810,175 | $34.0M | 2.32% |
| 16 | ALKERMES PLC | ALKS | 1,375,000 | $33.1M | 2.26% |
| 17 | VIRIDIAN THERAPEUTICS INC | VRDN | 2,528,032 | $32.9M | 2.25% |
| 18 | KURA ONCOLOGY INC | KURA | 1,593,350 | $32.8M | 2.24% |
| 19 | NKARTA INC | NKTX | 4,151,034 | $24.5M | 1.67% |
| 20 | CELCUITY INC | CELC | 1,464,105 | $24.0M | 1.64% |
| 21 | THIRD HARMONIC BIO INC | 88427A107 | 1,545,426 | $20.1M | 1.37% |
| 22 | IMMUNOVANT INC | IMVT | 750,990 | $19.8M | 1.35% |
| 23 | ABIVAX SA | AAVXF | 1,284,110 | $17.0M | 1.16% |
| 24 | SYNDAX PHARMACEUTICALS INC | SNDX | 825,000 | $16.9M | 1.16% |
| 25 | C4 THERAPEUTICS INC | CCCC | 3,410,384 | $15.8M | 1.08% |
| 26 | ORIC PHARMACEUTICALS INC | ORIC | 2,000,000 | $14.1M | 0.97% |
| 27 | APOGEE THERAPEUTICS INC | APGE | 290,000 | $11.4M | 0.78% |
| 28 | CABALETTA BIO INC | CABA | 1,100,000 | $8.2M | 0.56% |
| 29 | PERCEPTIVE CAP SOLUTIONS COR | G70077105 | 750,000 | $7.5M | 0.52% |
| 30 | NEUROGENE INC | NGNE | 200,000 | $7.3M | 0.50% |
| 31 | VISTAGEN THERAPEUTICS INC | VTGN | 1,575,000 | $5.5M | 0.37% |
| 32 | HELIX ACQUISITION CORP II | HLXC | 500,000 | $5.1M | 0.35% |
| 33 | AUTOLUS THERAPEUTICS PLC | AUTL | 1,178,723 | $4.1M | 0.28% |
| 34 | ARCA BIOPHARMA INC | 00211Y506 | 414,325 | $1.6M | 0.11% |
| 35 | AVALO THERAPEUTICS INC | AVTX | 40,000 | $498,800 | 0.03% |